12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hepoxal inositol nicotinate regulatory update

Genus Pharmaceuticals Ltd., Newbury, U.K.
Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan
sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France
Product: Hepoxal inositol nicotinate; Pletal cilostazol; Trental 400 pentoxifylline...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >